Peptidylgycine α-amidating monooxygenase and copper: A gene-nutrient interaction critical to nervous system function

Journal of Neuroscience Research

Volumn 88, Issue 12, 2010, Pages 2535-2545

  Bousquet Moore, Danielle ^a   Mains, Richard E ^a   Eipper, Betty A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Amidation; Nutrition; Peptide

Indexed keywords

COPPER; ENZYME; NEUROPEPTIDE; NEUROPEPTIDE Y; UNSPECIFIC MONOOXYGENASE;

ALZHEIMER DISEASE; AMIDATION; ANXIETY; ATAXIA; BEHAVIOR DISORDER; CANCER CELL CULTURE; CATALYSIS; COPPER DEFICIENCY; CYTOLOGY; EUKARYOTE; GENE EXPRESSION; GENE INTERACTION; GENETIC ANALYSIS; HETEROZYGOSITY; HOMEOSTASIS; HUMAN; IN VIVO STUDY; NERVOUS SYSTEM FUNCTION; NONHUMAN; NUTRIENT; PEPTIDE SYNTHESIS; PEPTIDERGIC NERVOUS SYSTEM; PERINATAL PERIOD; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SEIZURE; SENSOR; THERMOREGULATION;

ANIMALS; COPPER; CYTOSOL; DISEASE MODELS, ANIMAL; ENDOCYTOSIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART ATRIA; HUMANS; MICE; MIXED FUNCTION OXYGENASES; MULTIENZYME COMPLEXES; NERVOUS SYSTEM DISEASES; NEUROPEPTIDES; PITUITARY DISEASES; PROTEIN TRANSPORT;

EID: 77955499229     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22404     Document Type: Review

References (128)

1. Alam MR, Caldwell BD, Johnson RC, Darlington DN, Mains RE, Eipper BA. 1996. Novel proteins that interact with the COOH-terminal cytosolic routing determinants of an integral membrane peptide-processing enzyme. J Biol Chem 271:28636-28640.
2. Alam MR, Johnson RC, Darlington DN, Hand TA, Mains RE, Eipper BA. 1997. Kalirin, a cytosolic protein with spectrin-like and GDP/ GTP exchange factor-like domains that interacts with peptidylglycine β-amidating monooxygenase, an integral membrane peptide-processing enzyme. J Biol Chem 272:12667-12675.
3. Al-Bitar Y, Azam JS, Azam T. 2005. Menke's kinky hair syndrome - a rare medical condition. J Pak Med Assoc 55:40-42. (Pubitemid 40476984)
4. Andreini C, Banci L, Bertini I, Rosato A. 2008. Occurence of copper proteins through the three domains of life: a bioinformatic approach. J Proteome Res 7:209-216. (Pubitemid 351171133)
5. Asada A, Orii H, Watanabe K, Tsubaki M. 2005. Planarian peptidylglycine-hydroxylating monooxygenase, a neuropeptide processing enzyme, colocalizes with cytochrome b561 along the central nervous system. FEBS J 272:942-955.
6. Associated Press. 2009. Overuse of denture cream with zinc sparks lawsuits. N Y Times, Sept. 18, 2009.
7. Bahi-Buisson N, Kaminska A, Nabbout R, Barnerias C, Desquere I, De Lonlay P, Mayer M, Plouin P, Dulac O, Chiron C. 2006. Epilepsy in Menkes disease: analysis of clinical stages. Epilepsia 47:380-386.
8. Bayer TA, Schafer S, Breyhan H, Wirths O, Treiber C, Multhaup G. 2006. A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease. Clin Neuropathol 25:163-171.
9. Bell J, El Meskini R, D'Amato D, Mains RE, Eipper BA. 2003. Mechanistic investigation of peptidylglycine alpha-hydroxylating monooxygenase via intrinsic tryptophan fluorescence and mutagenesis. Biochemistry 42:7133-7142.
10. Blackburn NJ, Hasnain SS, Pettingill TM, Stranger RW. 1991. Copper K-extended X-ray absorption fine structure studies of oxidized and reduced dopamine beta-hydroxylase. J Biol Chem 266:23127.
11. Booth RE, Misquitta SA, Bateman RC. 2003. Human pituitary glutaminyl cyclase: expression in insect cells and dye affinity purification. Protein Expr Purif 32:141-146.
12. Bousquet-Moore D, Ma XM, Nillni EA, Czyzyk TA, Pintar JE, Eipper BA, Mains RE. 2009a. Reversal of physiological deficits caused by diminished levels of peptidylglycine alpha-amidating monooxygenase by dietary copper. Endocrinology 150:1739-1756.
13. Bousquet-Moore D, Prohaska JR, Nillni EA, Czyzyk TA, Wetsel WC, Mains RE, Eipper BA. 2009b. Interactions of peptide amidation and copper: novel biomarkers and mechanisms of neural dysfunction. Neurobiol Dis 37:130-140.
14. Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B, Junien JL. 1995. Behavioral effects of neuropeptide Y receptor antagonists in the elevated plus-maze and fear-potentiated startle procedures. Behav Pharmacol 6:215-222.
15. Caldwell BD, Darlington DN, Penzes P, Johnson RC, Eipper BA, Mains RE. 1999. The novel kinase P-CIP2 interacts with the cytosolic routing determinants of the peptide processing enzyme peptidylglycine α-amidating monooxygenase. J Biol Chem 274:34646-34656.
16. Caron KM, Smithies O. 2001. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc Natl Acad Sci U S A 98:615-619. (Pubitemid 32105091)
17. Chen L, Johnson RC, Milgram SL. 1998. P-CIP1, a novel protein that interacts with the cytosolic domain of peptidyglycine α-amidating monooxygenase, is associated with endosomes. J Biol Chem 273: 33524-33532.
18. Chen P, Bell J, Eipper BA, Solomon EI. 2004. Oxygen activation by the noncoupled binuclear copper site in peptidylglycine alpha-hydroxylating monooxygenase: spectroscopic definition of the resting sates and the putative CuIIM-OOH intermediate. Biochemistry 43:5735-5747.
19. Christodoulou J, Danks DM, Sarkar B, Baerloucher KE, Casey R, Horn N, Tumer Z, Clarke JT. 1998. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients. Am J Med Genet 72:154-164.
20. Chufan EE, De M, Eipper BA, Mains RE, Amzel LM. 2009. Amidation of bioactive peptides: the structure of the lyase domain of the amidating enzyme. Structure 17:1-9.
21. Ciccotosto GD, Schiller MR, Eipper BA, Mains RE. 1999. Induction of integral membrane PAM expression in AtT-20 cells alters the storage and trafficking of POMC and PC1. J Cell Biol 144:459-471.
22. Ciccotosto GD, Hand TA, Mains RE, Eipper BA. 2000. Breeding stockspecific variation in PAM mRNA splicing in rat pituitary. Endocrinology 141:476-486.
23. Crichton RR, Pierre JL. 2001. Old iron, young copper: from Mars to Venus. Biometals 14:99-112.
24. Czyzyk TA, Ning Y, Hsu MS, Peng B, Mains RE, Eipper BA, Pintar JE. 2005. Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse. Dev Biol 287:301-313.
25. Dark J, Pelz KM. 2008. NPY Y1 receptor antagonist prevents NPY-induced torporlike hypothermia in cold-acclimated Siberian hamsters. Am J Physiol Reg Integr Comp Physiol 294:R236-R245.
26. De M, Bell J, Blackburn NJ, Mains RE, Eipper BA. 2006. Role for an essential tyrosine in peptide amidation. J Biol Chem 281:20873-20882.
27. De M, Ciccotosto GD, Mains RE, Eipper BA. 2007. Trafficking of a secretory granule membrane protein is sensitive to copper. J Biol Chem 282:23362-23371.
28. Dhanvantari S, Brubaker PL. 1998. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion. Endocrinology 139:1630-1637. (Pubitemid 28513818)
29. Eipper BA, Mains RE. 1988. Peptide alpha-amidation. Annu Rev Physiol 50:333-344.
30. Eipper BA, Stoffers DA, Mains RE. 1992. The biosynthesis of neuropeptides: peptide alpha-amidation. Annu Rev Neurosci 15:57-85.
31. Ferraro F, Ma XM, Sobota JA, Eipper BA, Mains RE. 2007. Kalirin/ Trio Rho guanine nucleotide exchange factors regulate a novel step in secretory granule maturation. Mol Biol Cell 18:4813-4825.
32. Francisco WA, Blackburn NJ, Klinman JP. 2003. Oxygen and hydrogen isotope effects in an active site tyrosine to phenylalanine mutant of peptidylglycine alpha-hydroxylating monooxygenase: mechanistic implications. Biochemistry 42:1813-1819.
33. Francone VP, Ifrim MF, Rajagopal C, Wang Y, Carson JH, Mains RE, Eipper BA. 2010. Signaling from the secretory granule to the nucleus: PAM and Uhmk1. Mol Endocrinol (in press).
34. Glauder J, Ragg H, Rauch J, Engels JW. 1990. Human peptidylglycine α-amidating monooxygenase: cDNA, cloning, and expression of a truncated form in COS cells. Biochem Biophys Res Commun 169: 551-558.
35. Goldstein DS, Holmes CS, Kaler SG. 2009. Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of menkes disease. Neurochem Res 34:1464-1468.
36. Gonzalez H, Ottervald J, Nilsson KC, Sjogren N, Olsson T, Franzen B. 2009. Identification of novel candidate protein biomarkers for the postpolio syndrome - implications for diagnosis, neurodegeneration and neuroinflammation. J Proteom 71:670-681.
37. Grimmelikhuijzen CJP, Leviev I, Carstensen K. 1996. Peptides in the nervous systems of cnidarians: structure, function and biosynthesis. Int Rev Cytol 167:37-89.
38. Gutierrez-Mariscal M, de Gortari P, Lopez-Rubaicava C, Joseph-Bravo P. 2008. Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety. Psychoneuroendocrinology 33:198-213.
39. Hardiman A, Friedman TC, Grunwald WC, Furuta M, Zhu Z, Steiner DF, Cool DR. 2005. Endocrinomic profile of neurointermediate lobe pituitary prohormone processing in PC1/3 and PC2-null mice using SELDI-TOF mass spectrometry. J Mol Endocrinol 34:751.
40. Hay DL, Smith DM. 2001. Knockouts and transgenics confirm the importance of adrenomedullin in the vasculature. Trends Pharmacol Sci 22:57-59.
41. Holtzman NA, Gaumnitz BM. 1970. Studies of the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma. J Biol Chem 245:2354-2358.
42. Hung YH, Robb EL, Volitakis I, Ho M, Cherny RA, Bush AI. 2009. Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease. J Biol Chem 284:21899-21907.
43. Hwa J, Witten M, Williams P, Ghibaudi L, Gao J, Salisbury B, Mullins D, Hamud F, Strader CD, Parker EM. 1999. Activation of the NPY Y5 receptor regulates both feeding and energy expenditure. Am J Physiol Reg Integr Comp Physiol 277:R1428-R1434.
44. In Y, Fujii M, Sasada Y, Ishida T. 2001. Structural studies on C-amidated amino acids and peptides: structures of hydrochloride salts of C-amidated Ile-Val, Thr, Ser, Met, Trp, Gln, and Arg, and comparison with their C-unamidated counterparts. Acta Crystallogr Sect B Struct Sci 203:631-639.
45. Jackson RS, Creemers JWM, Farooqui S, Raffin-Sanson ML, Varro A, Dockary GJ, Holst JJ, Brubaker PL, Corvol P, Polonsky KS, Ostrega D, Becker KL, Bertagna X, Hutton JC, White A, Dattani MT, Hussain K, Middleton SJ, Nicole TM, Milla PJ, Lindley KJ, O'Rahilly S. 2003. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 112:1550-1560.
46. Jahng JW, Houpt TA, Joh TH, Wessell TC. 1997. Expression of catecholamine-synthesizing enzymes, peptidylglycine alpha-amidating monooxygenase, and neuropeptide mRNA in the rat adrenal medulla after acute systemic nicotine. J Mol Neurosci 8:45-52.
47. Jaworska Feil L, Turchan J, Przewlocka B, Budziszewska B, Leskiewicz M, Lason W. 1999a. Effects of pentylenetetrazole-induced kindling on thyrotropin-releasing hormone biosynthesis and receptors in rat brain. Neuroscience 90:695-704. (Pubitemid 29161416)
48. Jaworska Feil L, Turchan J, Przewlocka B, Budziszewska B, Leskiewicz M, Lason W. 1999b. Effects of pilocarpine- and kainate-induced seizures on thyrotropin-releasing hormone biosynthesis and receptors in the rat brain. J Neural Transm 106:395-407. (Pubitemid 29273881)
49. Jiang N, Kolhekar AS, Jacobs PS, Mains RE, Eipper BA, Taghert PH. 2000. PHM is required for normal developmental transitions and for biosynthesis of secretory peptides in Drosophila. Dev Biol 226:118-136.
50. Kaler SG. 1998. Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency. Am J Clin Nutr 67:1029S-1034S.
51. Kaler SG, Holmes CS, Goldstein DS, Tang J, Godwin SC, Patronas N. 2008. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med 358:605-614.
52. Kessler H, Pajonk FG, Meisser P, Schneider-Axmann T, Hoffman KH, Supprian T, Herrman W, Obeid R, Multhaup G, Falkai P, Bayer TA. 2006. Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease. J Neural Transm 113:1763-1769. (Pubitemid 44657672)
53. Kim BE, Nevitt T, Thiele DJ. 2008. Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol 4:176-185.
54. Klevay LM. 2000a. Cardiovascular disease from copper deficiency - a history. J Nutr 130:489S-492S.
55. Klevay LM. 2000b. Dietary copper and risk of coronary heart disease. Am J Clin Nutr 71:1213-1214.
56. Klinman JP. 2008. The copper-family of dopamine β-monooxygenase and peptidylglycine α-amidating. J Biol Chem 281:3016.
57. Kolhekar AS, Roberts MS, Jiang N, Johnson RC, Mains RE, Eipper BA, Taghert PH. 1997. Neuropeptide amidation in Drosophila: separate genes encode the two enzymes catalyzing amidation. J Neurosci 17: 1363-1376.
58. Kolhekar AS, Bell J, Shiozaki EN, Jin L, Keutmann HT, Hand TA, Mains RE, Eipper BA. 2002. Essential features of the catalytic core of peptidyl-????-hydroxyglycine α-amidating lyase. Biochemistry 41: 12384-12394.
59. Lloyd DJ, Bohan S, Gekakis N. 2006. Obesity, hyperphagia, and increased metabolic efficiency in Pc1 mutant mice. Hum Mol Genet 15:1884-1893. (Pubitemid 43821779)
60. Lominadze D, Saari JT, Pericival SS, Schuschke DA. 2004. Proinflammatory effects of copper deficiency on neutrophils and lung endothelial cells. Immunol Cell Biol 82:238.
61. Ma XM, Mains RE, Eipper BA. 2002. Plasticity in hippocampal peptidergic systems induced by repeated electroconvulsive shock. Neuropsychopharmacology 27:55-71.
62. Ma XM, Wang Y, Ferraro F, Mains RE, Eipper BA. 2008. Kalirin-7 Is an essential component of both shaft and spine excitatory synapses in hippocampal interneurons. J Neurosci 28:711-724.
63. Madsen E, Gitlin JD. 2007. Copper and iron disorders of the brain. Annu Rev Neurosci 30:317-337.
64. Madsen E, Gitlin JD. 2008. Zebrafish mutants calamity and catastrophe define critical pathways of gene-nutrient interactions in developmental copper metabolism. PLOS Genet 4:1-10.
65. Mains RE, Myers AC, Eipper BA. 1985. Hormonal, drug, and dietary factors affecting peptidyl glycine alpha-amidating monooxygenase activity in various tissues of the adult male rat. Endocrinology 116:2505-2515.
66. Mains RE, Alam MR, Johnson RC, Darlington DN, Back N, Hand TA, Eipper BA. 1999. Kalirin, a multifunctional PAM COOH-terminal domain interactor protein, affects cytoskeletal organization and ACTH secretion from AtT-20 cells. J Biol Chem 274:2929-2937.
67. Mair GR, Niciu MJ, Stewart MT, Brennan G, Omar H, Halton DW, Mains RE, Eipper BA, Maule AG, Day TA. 2004. A functionally atypical amidating enzyme from the human parasite Schistosoma mansoni. FASEB J 18:114-121.
68. Matthews KA, Kunte AS, Tambe-Ebot E, Rawson RB. 2009. Alternative activation of SREBP during larval development in Drosophila melanogaster. Genetics 181:119-128.
69. Maury A, Payen V, Toutain A, Guiraud P, Saliba E, Labarthe F. 2007. Neonatal onset of Menkes disease: diagnosis interest of cupremia and microscopic examination of the hairs. Arch Pediatr 14:1216-1218.
70. Mendelsohn BA, Yin C, Johnson SL, Wilm TP, Solnica-Krezel L, Gitlin JD. 2006. ATP7a determines a hierarchy of copper metabolism essential for notochord development. Cell Metab 4:155-162. (Pubitemid 44138717)
71. Merkler DJ. 1994. C-terminal amidated peptides: production by the in vitro enzymatic amdiation of glycine-extended peptides and the importance of the amide to biological activity. Ezyme Microb Technol 16:450-456.
72. 13C NMR shift as proof th bifunctional peptidylglycine α-amidating enzyme is a monooxygenase. Biochemistry 31:7282-7288.
73. Milgram SL, Kho ST, Martin GV, Mains RE, Eipper BA. 1997. Localization of integral membrane peptidylglycine α-amidating monooxygenase in neuroendocrine cells. J Cell Sci 110:695-706.
74. Muller L, Lindberg I. 1999. The cell biology of the prohormone convertases PC1 and PC2. Prog Nucleic Acid Res Mol Biol 63:69-108.
75. Nagara H, Yajima K, Suzuki K. 1981. The effect of copper supplementation on the brindled mouse. J Neurol Exp Neurol 40:428-446.
76. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen BJ, Leiter EH. 1995. Hyperinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 10:135-142.
77. Niciu MJ, Ma XM, El Meskini R, Pachter JS, Mains RE, Eipper BA. 2007. Altered ATP7a expression and other compensatory responses in a murine model of Menkes disease. Neurobiol Dis 27:278-291.
78. Nie Y, Shoepp DD, Klaunig JG, Yard M, Lahiri DK, Kubek MJ. 2005. Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro. Brain Res 1054:45-54. (Pubitemid 41188128)
79. Nittis T, Gitlin JD. 2004. Role of copper in the proteosome-mediated degradation of the multicopper oxidase hephaestin. J Biol Chem 279:25696-25702.
80. Noguchi H, Seino H, Kochi H, Okamoto H, Tanaka T, Hirama M. 1992. The source of the oxygen aton in the α-hydroxyglycine intermediate of the peptidylglycine α-amidating reaction. Biochem J 283:883-888.
81. Ouafik LH, May V, Saffen DW, Eipper BA. 1990. Thyroid hormone regulation of peptidylglycine α-amidating monooxygenase expression in anterior pituitary gland. Mol Endocrinol 4:1497-1505.
82. Ozawa H, Nakamoto N, Kodama H. 2002. Clinical manifestations for early diagnosis of the patient with classical Menkes disease. No To Hattatsu 34:387-390. (Pubitemid 34994288)
83. Padilla J, Garcia-Villalon AL, Monge L, Garcia JL, Fernandez N, Gomez B, Diequez G. 1997. Peptidergic modulation of the sympathetic contraction in the rabbit ear artery: effects of temperature. Br J Pharmacol 121:21-28.
84. Pelz KM, Dark J. 2007. ICV NPY Y1 agonist but not Y5 agonist induces torpor-like hypothermia in cold-acclimated Siberian hamsters. Am J Physiol Reg Integr Comp Physiol 292:R2299-R2311.
85. Penland JG, Prohaska JR. 2004. Abnormal motor function persists following recovery from perinatal copper deficiency in rats. J Nutr 134:1984-1988.
86. Prigge ST, Kolhekar AS, Eipper BA, Mains RE, Amzel LM. 1997. Amidation of bioactive peptides: the structure of peptidylglycine α-hydroxylating monooxygenase. Science 278:1300-1305.
87. Prigge ST, Kolhekar AS, Eipper BA, Mains RE, Amzel LM. 1999. Substrate-mediated electron transfer in peptidylglycine alpha-hydroxylating monooxygenase. Nat Struct Biol 6:976-983.
88. Prigge ST, Mains RE, Eipper BA, Amzel LM. 2000. New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell Mol Life Sci 57:1236-1259.
89. Prigge ST, Eipper BA, Mains RE, Amzel LM. 2004. Dioxygen binds end-on to mononuclear copper in a precatalytic enzyme complex. Science 304:864-867. (Pubitemid 38620184)
90. Prohaska JR, Broderius M. 2006. Plasma peptidylglycine alpha-amidating monooxygenase (PAM) and ceruloplasmin are affected by age and copper status in rats and mice. Comp Biochem Physiol B Biochem Mol Biol 143:360-366.
91. Prohaska JR, Wells WW. 1974. Copper deficiency in the developing rat brain: a possible model for Menkes' steely hair disease. J Neurochem 23:91-98.
92. Prohaska JR, Broderius M, Brokate B. 2003. Metallochaperone for Cu,Zn-superoxide dismutase (CCS) protein, but not mRNA is higher in organs from copper deficient mice and rats. Arch Biochem Biophys 417:227-234.
93. Prohaska JR, Gybina AA, Broderius M, Brokate B. 2005. Peptidylglycine- alpha-amidating monooxygenase activity and protein are lower in copper-deficient rats and suckling copper-deficient mice. Arch Biochem Biophys 434:212-220.
94. Pyatskowit JW, Prohaska JR. 2008. Iron injection restores brain iron and hemoglobin deficits in perinatal copper-deficient rats. J Nutr 138:1880-1886.
95. Rajagopal C, Stone KL, Francone V, Mains RE, Eipper BA. 2009. Secretory granule to the nucleus: role of a multiply phosphorylated intrinsically unstructured domain. J Biol Chem 284:25723-25734.
96. Richichi C, Lin ED, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A. 2004. Anticonvulsant and antiepileptic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci 24:3051-3059.
97. Ridge PG, Zhang Y, Gladeyshev VN. 2008. Comparative genomic analyses of copper transporters and cuproproteomes reveal evolutionary dynamics of copper utilization and its link to oxygen. PLoS ONE 3:e1378. (Pubitemid 351761613)
98. Sandberg R, Yasuda R, Pankratz D, Carter T, Lockhart D, Barlow C. 2000. Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci U S A 97:11043.
99. Sanders L. 2009. Fear of falling. N Y Times Magazine, Sept. 2, 2009.
100. Schilling S, Niestroj AJ, Rahfeld JU, Hoffmann T, Wermann M, Zunkel K, Wasternack C, Demuth HU. 2003. Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators. J Biol Chem 278:49773-49779.
101. Scientific Committee on Food, European Commission on Health and Consumer Protection Directorate. 2003. Opinion of the Scientific Committee on Food on the tolerable upper level intake of copper.
102. Sharma SD, Raghuraman G, Lee MS, Prabhakar NR, Kumar GK. 2009. Intermittent hypoxia activates peptidylglycine alpha-amidating monooxygenase in rat brain stem via reactive oxygen species-mediated proteolytic processing. J Appl Physiol 106:12-19.
103. Sheela SR, Latha M, Lui P, Lem K, Kaler SG. 2005. Copper-replacement treatment for symptomatic Menkes disease: ethical considerations. Clin Genet 68:278-283.
104. Shintani M, Tamura Y, Monden M, Shiomi H. 2005. Thyrotropin-releasing hormone induced thermogenesis in Syrian hamsters: site of action and receptor subtype. Brain Res 1039:22-29.
105. Siebert X, Eipper BA, Mains RE, Prigge ST, Blackburn NJ, Amzel LM. 2005. The catalytic copper of peptidylglycine alpha-hydroxylating monooxygenase also plays a critical structural role. Biophys J 89:3312-3319. (Pubitemid 41636086)
106. Silva E. 2006. Thermogenic mechanisms and their hormonal regulation. Physiol Rev 86:435-464.
107. Sorensen AT, Kanter-Schlifke I, Lin ED, During MJ, Kokaia M. 2008. Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum. Mol Cell Neurosci 39:229-237.
108. Sorensen AT, Nikitidou L, Ledri M, Lin ED, During MJ, Kanter-Schlifke I, Kokaia M. 2009. Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP. Exp Neurol 215:328-333.
109. Sosulina L, Schwesig G, Seifert G, Pape HC. 2008. Neuropeptide Y activates a G-protein-coupled inwardly rectifying potassium current and dampens excitability in the lateral amygdala. Mol Cell Neurosci 39:498.
110. Sperk G, Furtinger S, Schwarzer C, Pirker S. 2004. GABA and its receptors in epilepsy. Adv Exp Med Biol 548:92-103.
111. Stephens DP, Saad AR, Bennett LA, Kosiba WA, Johnson JM. 2004. Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans. Am J Physiol Heart Circ Physiol 287:H1404-H1409.
112. Steveson TC, Zhao GC, Keutmann HT, Mains RE, Eipper BA. 2001. Access of a membrane protein to secretory granules is facilitated by phosphorylation. J Biol Chem 276:40326-40337.
113. Steveson TC, Ciccotosto GD, Ma XM, Mueller GP, Mains RE, Eipper BA. 2003. Menkes protein contributes to the function of peptidylglycine alpha-hydroxylating monooxygenase. Endocrinology 144:188-200.
114. Strausak D, Mercer JF, Dieter HH, Stremmel W, Multhaup G. 2001. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull 55:175-185. (Pubitemid 32722157)
115. Tan JC, Burns DL, Jones HR. 2006. Severe ataxia, myelopathy, and peripheral neuropathy due to acquired copper deficiency in a patient with history of gastrectomy. J Parenter Enter Nutr 30:446-450.
116. Tokuda Y, Kashima M, Kayo M, Nakazato N, Stein GH. 2006. Cocoa supplementation for copper deficiency associated with tube feeding nutrition. Intern Med 45:1079-1085.
117. Trajkovski M, Mziaut H, Altkrüger A, Ouwendijk J, Knoch KP, Müller S, Solimena M. 2004. Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in β-cells. J Cell Biol 16:1063-1074.
118. Truitt WA, Johnson PL, Dietrich AD, Fitz SD, Shekar A. 2009. Anxiety-like behavior is modulated by a discrete subpopulation of interneurons in the basolateral amygdala. Neuroscience 160:284-294.
119. Tsukumo Y, Tomida A, Kitahara O, Nakamura Y, Asada S, Mori K, Tsuruo T. 2007. Nucleobindin 1 controls the unfolded protein response by inhibiting ATF6 activation. J Biol Chem 282:29264-29272.
120. Tumer Z, Horn N. 1997. Menkes disease: recent advances and new aspects. J Med Genet 34:265-274. (Pubitemid 27208029)
121. Veasey S. 2009. Peptide amidation: a push me, don't pull you for the morbidities in sleep apnea. J Appl Physiol 106:4.
122. Veronesi MC, Kubek DJ, Kubek MJ. 2007. Intranasal delivery of a thyrotropin-releasing hormone analog attenuates seizures in the amygdalakindled rat. Epilepsia 48:2280-2286.
123. von Drygalski A, Andris DA. 2009. Anemia after bariatric surgery: more than just iron deficiency. Nutr Clin Pract 24:217-226.
124. Vos MD, Jones JE, Treston AM. 1995. Human peptidylglycine alpha-amidating monooxygenase transcripts derived by alternative mRNA splicing of an unreported exon. Gene 163:307-311.
125. Walker JM, Huster D, Ralle M, Morgan CT, Blackburn NJ. 2004. The N-terminal metal binding 2 of the Wilson's disease protein plays a key role in the transfer of copper from Atox-1. J Biol Chem 279:15376-15384.
126. Wand GS, Ney RL, Baylin S, Eipper BA, Mains RE. 1985. Characterization of a peptide alpha-amidation activity in human plasma and tissues. Metabolism 34:1044-1052.
127. Woronowicz A, Cawley NX, Chang SY, Koshimizu H, Phillips AW, Ziong ZG, Loh YP. 2009. Carboxypeptidase E knockout mice exhibit abnormal dendritic arborization and spine morphology in central nervous system neurons. J Neurosci Res PMID: 19598241.
128. Xin X, Mains RE, Eipper BA. 2005. Monooxygenase X, a member of the copper-dependent monooxygenase family localized to the endoplasmic reticulum. J Biol Chem 279:48159-48167.